GlassScriptPhysician profile
Ayush Arora
NPI 1144672320
$7,777.75
in general payments reported to CMS, 2019-2025
34 companies · $754 in 2025
The $754 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.30 · 2022: $176 · 2023: $5,553 · 2024: $1,273 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,579.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $2,476.21 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $895.61 | 2023-2025 | Impella |
| Medtronic, INC. | $563.31 | 2023 | Corevalve Evolut R, Hawkone, In.Pact Admiral |
| Novartis Pharmaceuticals Corporation | $484.01 | 2023-2025 | |
| Bard Peripheral Vascular, INC. | $401.04 | 2023 | Venovo, Crosser Iq, Lifestream |
| Terumo Medical Corporation | $399.02 | 2023 | Metacross Otw, Angio-Seal, Heartrail |
| Amgen INC. | $375.45 | 2022-2025 | Repatha, Repatha |
| Abbott Laboratories | $365.07 | 2023-2024 | Cardiomems, Dragonfly Opstar, Diamondback Coronary |
| Boston Scientific Corporation | $280.53 | 2023-2024 | Mdu5 Plus Sterile Bag, Filterwire Ez, Varithena Administration Pack |
| Pfizer INC. | $165.41 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.05 | 2023-2024 | Lifevest |
| Philips North America LLC | $157.75 | 2022-2024 | (Br5) Peripheral Ivus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.24 | 2023-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $118.04 | 2023-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $94.08 | 2024-2025 | Onpattro |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $81.74 | 2023 | Farxiga |
| Cagent Vascular INC | $80.33 | 2023 | Serrantor |
| Kestra Medical Technology Services, INC. | $74.97 | 2023-2024 | Assure Wcd |
| Angiodynamics, INC. | $70.68 | 2025 | Auryon Laser System 100-120 Vac |
| Becton, Dickinson and Company | $56.87 | 2024 | Venclose Maven Catheter |
| Merck Sharp & Dohme LLC | $55.00 | 2025 | Verquvo |
| W. L. Gore & Associates, INC. | $31.24 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Mannkind Corporation | $25.49 | 2025 | |
| Chiesi USA, INC. | $24.37 | 2023 | Kengreal |
| Itamar Medical INC | $24.30 | 2024 | Watchpatone |
| Actelion Pharmaceuticals US, INC. | $22.42 | 2023 | Uptravi |
| Asahi Intecc USA, INC. | $22.41 | 2023 | Asahi Ptca Guide Wire |
| Janssen Pharmaceuticals, INC | $21.68 | 2024 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $20.62 | 2025 | Evkeeza |
| Stryker Corporation | $20.30 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Scpharmaceuticals INC. | $19.91 | 2024 | |
| Novo Nordisk INC | $19.05 | 2024 | Ozempic |
| Lexicon Pharmaceuticals, INC. | $17.43 | 2024 | |
| Cordis US Corp. | $16.12 | 2024 | Mynx Control |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayush Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.